Floatz logo

Tenofovir Bis(Isopropyloxycarbonyloxymethyl) Ester

Osteoporosis

University College DublinSmall moleculePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Osteoporosis cohort.

Asset / SponsorPhaseRating
Risedronic Acid
Susan L. Greenspan
Phase 4BBB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BBB
Vitamin D
Benha University
Phase 4BBB
Alendronic Acid
University College Dublin
Phase 4BBB
Medroxyprogesterone
Peking Union Medical College Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Tenofovir Bis(Isopropyloxycarbonyloxymethyl) Ester is also rated in:

hepatitis B virus infectionActive
BB
Indicative · Phase 4
70 / 100
View asset →
B-cell non-Hodgkin lymphomaDormant
B
Indicative · Phase 3
60 / 100
View asset →
primary biliary cholangitisDormant
B
Indicative · Phase 2
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →